Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TREMFYA DIN 02570890

Status: Approved
Holder: JANSSEN INC
Molecule: GUSELKUMAB

Health Canada record

Active ingredient(s)GUSELKUMAB 45 MG
Dosage formSolution
RouteSubcutaneous
SchedulePRESCRIPTION; SCHEDULE D
ClassHuman
ATCL04AC16 GUSELKUMAB
Original market date
Current status date14-Aug-2026
SourceHealth Canada DPD

Establishment licence of the holder

Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing GUSELKUMAB

DINProductCompanyFormStrengthStatus
02469758TREMFYAJANSSEN INCSolutionGUSELKUMAB 100 MGMarketed
02559137TREMFYAJANSSEN INCSolutionGUSELKUMAB 200 MGApproved
02559145TREMFYAJANSSEN INCSolutionGUSELKUMAB 200 MGMarketed
02566877TREMFYAJANSSEN INCSolutionGUSELKUMAB 100 MGMarketed
02559153TREMFYA I.V.JANSSEN INCSolutionGUSELKUMAB 200 MGMarketed
02487314TREMFYA ONE-PRESSJANSSEN INCSolutionGUSELKUMAB 100 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
381132026-08-14Supplement to a New Drug Submission (SNDS)New Indications: Plaque Psoriasis • (6 years to 17 years): TREMFYA (guselkumab injection) is indicated for the treatment of pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. • (< 6 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric patients less than 6 years of age. Psoriatic Arthritis • (6 years to 17 years): TREMFYA (guselkumab injection) is indicated in pediatric patients 6 years of age and older with active psoriatic arthritis supported by model-based extrapolation. • (< 6 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric patients less than 6 years of age.
Request a quote for TREMFYA

How to read a Canadian DIN record